Allogeneic hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria

European Journal of Haematology

Volumn 71, Issue 2, 2003, Pages 114-118

  Lee, Jae Lyun ^a   Lee, Je Hwan ^a,b   Lee, Jung Hee ^a   Choi, Seong Jun ^a   Kim, Shin ^a   Seol, Miee ^a   Lee, Young Shin ^a   Chi, Hyun Sook ^a   Park, Chan Jeoung ^a   Kim, Woo Kun ^a   Lee, Jung Shin ^a   Lee, Kyoo Hyung ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

Allogeneic hematopoietic cell transplantation; Conditioning therapy; PNH

Indexed keywords

ANDROGEN; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BONE MARROW CELL; CELL LINEAGE; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMAN; MALE; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; SIBLING; TREATMENT INDICATION;

ADOLESCENT; ADULT; ANTILYMPHOCYTE SERUM; BUSULFAN; DRUG THERAPY, COMBINATION; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINURIA, PAROXYSMAL; HISTOCOMPATIBILITY; HUMANS; MALE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 0041627526     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00097.x     Document Type: Article

References (23)

1. KINOSHITA T, INOUE N, TAKEDA J. Role of phosphatidylinositol-linked proteins in paroxysmal nocturnal hemoglobinuria pathogenesis. Annu Rev Med 1996;47:1-10.
2. ROSSE WF, WARE RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood 1995;86:3277-3286.
3. DUNN DE, TANAWATTANACHAROEN P, BOCCUNI P, NAGAKURA S, GREEN SW, KIRBY MR, KUMAR MS, ROSENFELD S, YOUNG SS. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med 1999;131:401-408.
4. PARKER CJ. Molecular basis of paroxysmal nocturnal hemoglobinuria. Stem Cells 1996;14:396-411.
5. HILLMEN P, LEWIS SM, BESSLER M, LUZZATTO L, DACIE JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-1258.
6. SOCIÉ G, MARY JY, de GRAMONT A, RIO B, LEPORRIER M, ROSE C, HEUDIER P, ROCHANT H, CAHN JY, GLUCKMAN E. Paroxysmal nocturnal haemoglobinura: long-term follow-up and prognostic factors. Lancet 1996;348:573-578.
7. KAWAHARA K, WITHERSPOON RP, STORB R. Marrow transplantation for paroxysmal nocturnal hemoglobinuria. Am J Hematol 1992;39:283-288.
8. BEMBA M, GUARDIOLA P, GARDERET L, DEVERGIE A, RIBAUD P, ESPEROU H, NOGUERA MH, GLUCKMAN E, SOCIE G. Bone marrow transplantation for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999;105:366-368.
9. SASO R, MARSH J, CEVRESKA L, et al. Bone marrow transplants for paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999;104:392-396.
10. SUENAGA K, KANDA Y, NIIYA H, et al. Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria. Exp Hematol 2001;29:639-642.
11. HALL SE, ROSSE WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood 1996;87:5332-5340.
12. LEE JH, LEE KH, CHOI SJ, et al. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2000;26:657-662.
13. LEE JH, LEE JH, KANG YK, LEE JS, KIM WK, LEE KH. Allogeneic non-myeloablative stem cell transplantation for the patients with heavily pre-treated refractory lymphoma. Haematologica 2001;86:1114-1115.
14. PRZEPIORKA D, WEISDORF D, MARTIN P, KLINGEMANN HG, BEATTY P, HOWS J, THOMAS ED. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825-828.
15. SULLIVAN KM, AGURA E, ANASETTI C, APPELBAUM F, BADGER C, BEARMAN S, ERICKSON K, FLOWERS M, HANSEN J, LOUGHRAN T. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991;28:250-259.
16. MCDONALD GB, HINDS MS, FISHER LD, SCHOCH HG, WOLFORD JL, BANAJI M, HARDIN BJ, SHULMAN HM, CLIFT RA. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993;118:255-267.
17. CHOI SJ, LEE KH, LEE JH, KIM S, CHUNO HJ, LEE JS, KIM SH, PARK CJ, CHI HS, KIM WK. Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 2000;26:327-332.
18. ENDO M, BEATTY PG, VREEKE TM, WITTWER CT, SINGH SP, PARKER CJ. Syngeneic bone marrow transplantataion without conditioning in a patient with paroxysmal nocturnal hemoglobinuria: in vivo evidence that the mutant stem cells have a survival advantage. Blood 1996;88:742-750.
19. DOUKAS MA, FLEMING D, JENNINGS D. Identical twin marrow transplantation for venous thrombosis in paroxysmal nocturnal hemoglobinuria; long-term complete remission as assessed by flow cytometry. Bone Marrow Transplant 1998;22:717-721.
20. RAIOLA AM, VAN LINT MT, LAMPARELLI T, et al. Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Haematologica 2000;85:59-62.
21. WOODARD P, WANG W, PITTS N, BENAIM E, HORWITZ E, CUNNINGNAM J, BOWMAN L. Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria. Bone Marrow Transplant 2001;27:589-592.
22. KHOURI IF, KEATING M, KORBLING M, et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. J Clin Oncol 1998;16:2817-2824.
23. SLAVIN S, NAGLER A, NAPARSTEK E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91:756-763.